Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

NCT00844155 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study has been withdrawn as the H1N1 epidemic made this study redundant

Conditions

Influenza A Virus Infection
Influenza B Virus Infection

Interventions

DRUG: Oseltamivir 75 mg

Sponsor

University of Manitoba

Collaborators

[object Object]